Transcatheter arterial chemoembolization plus apatinib with or without camrelizumab for unresectable hepatocellular carcinoma: a multicenter retrospective cohort study.
Duan X, Li H, Kuang D, Chen P, Zhang K, Li Y, He X, Xing C, Wang H, Liu Y, Xie L, Zhang S, Zhang Q, Zhu P, Dong H, Xie J, Li H, Wang Y, Shi M, Jiang G, Xu Y, Zhou S, Shang C, Ren J, Han X.
Duan X, et al. Among authors: li y, li h.
Hepatol Int. 2023 Aug;17(4):915-926. doi: 10.1007/s12072-023-10519-8. Epub 2023 Apr 3.
Hepatol Int. 2023.
PMID: 37012542
Free PMC article.